{"date": "2018-01-17_20:48:31", "url": "http://www.eurekalert.org/pub_releases/2017-01/jhm-cei010517.php", "year": "Thu, 05 Jan 2017 05:00:00 GMT", "text": ["experimental", "biology", "2017april", "22", "26", "2017chicago", "il2018", "aaas", "annual", "meeting", "february", "15", "19", "2018austin", "txresults", "initial", "study", "tumors", "patients", "lung", "cancer", "head", "neck", "cancer", "suggest", "widespread", "acquired", "resistance", "immunotherapy", "drugs", "known", "checkpoint", "inhibitors", "may", "due", "elimination", "certain", "genetic", "mutations", "needed", "enable", "immune", "system", "recognize", "attack", "malignant", "cells", "study", "conducted", "researchers", "cells", "five", "patients", "treated", "johns", "hopkins", "kimmel", "cancer", "center", "described", "online", "28", "cancer", "discovery", "checkpoint", "inhibitors", "one", "exciting", "recent", "advances", "cancers", "mechanism", "patients", "become", "resistant", "therapies", "mystery", "says", "victor", "velculescu", "program", "leader", "institute", "cancer", "immunotherapy", "johns", "hopkins", "professor", "oncology", "clinical", "trials", "drugs", "date", "shown", "nearly", "half", "patients", "lung", "cancers", "eventually", "develop", "resistance", "class", "drugs", "reasons", "unclear", "checkpoint", "inhibitors", "nivolumab", "ipilimumab", "approved", "fda", "use", "lung", "cancer", "metastatic", "melanoma", "head", "neck", "cancer", "hodgkin", "lymphoma", "help", "immune", "system", "recognize", "cancer", "cells", "revealing", "evidence", "mutated", "proteins", "called", "neoantigens", "surface", "cancer", "investigate", "checkpoint", "inhibitors", "often", "stop", "working", "velculescu", "valsamo", "anagnostou", "instructor", "oncology", "johns", "hopkins", "university", "school", "medicine", "kellie", "smith", "cancer", "immunology", "research", "associate", "johns", "hopkins", "university", "school", "medicine", "colleagues", "institute", "cancer", "immunotherapy", "studied", "tumors", "four", "patients", "cell", "lung", "cancer", "one", "patient", "head", "neck", "cancer", "developed", "resistance", "two", "different", "checkpoint", "inhibitors", "drug", "called", "nivolumab", "uses", "antibody", "called", "nivolumab", "used", "alone", "combination", "second", "drug", "called", "ipilimumab", "uses", "antibody", "called", "biopsies", "patients", "tumors", "collected", "start", "treatment", "time", "patients", "developed", "resistance", "researchers", "performed", "genomic", "analyses", "search", "mutations", "specific", "cancer", "cells", "patient", "scientists", "genomic", "search", "narrowed", "genes", "code", "production", "antigens", "serve", "source", "identification", "immune", "system", "cancer", "cells", "may", "contain", "mutations", "genes", "code", "antigens", "producing", "misshapen", "otherwise", "altered", "antigens", "known", "scientists", "neoantigens", "neoantigens", "foreign", "immune", "system", "thus", "cancer", "cell", "flagged", "destruction", "usually", "help", "immunotherapy", "drugs", "scientists", "found", "patients", "developed", "resistance", "immunotherapy", "tumors", "shed", "seven", "18", "mutations", "genes", "getting", "rid", "mutations", "tumor", "cells", "neoantigens", "look", "less", "foreign", "immune", "system", "may", "go", "unrecognized", "say", "scientists", "researchers", "found", "tumors", "lost", "mutations", "various", "means", "including", "elimination", "cancer", "cells", "containing", "mutations", "leaving", "behind", "cancer", "cells", "without", "mutations", "deleting", "large", "regions", "chromosomes", "cancer", "cells", "instances", "says", "anagnostou", "found", "chromosomes", "cancer", "cells", "nuclei", "missing", "entire", "arm", "containing", "mutated", "genes", "confirm", "missing", "mutations", "important", "generating", "immune", "response", "researchers", "cultured", "subset", "neoantigen", "protein", "fragments", "containing", "tumor", "mutations", "immune", "cells", "taken", "three", "patients", "blood", "samples", "one", "six", "eliminated", "neoantigens", "shown", "generate", "specific", "immune", "cell", "response", "patients", "findings", "offer", "evidence", "cancer", "cells", "evolve", "immunotherapy", "velculescu", "says", "cancer", "cells", "shed", "mutations", "discard", "evidence", "would", "normally", "lead", "recognized", "body", "protective", "immune", "cells", "velculescu", "anagnostou", "smith", "colleagues", "say", "plan", "determine", "broadly", "phenomenon", "occurs", "cancer", "types", "potentially", "use", "develop", "new", "ways", "improve", "current", "cancer", "immunotherapies", "example", "say", "mutated", "neoantigens", "present", "tumor", "cells", "therapy", "could", "give", "clues", "patients", "tumors", "might", "develop", "resistance", "findings", "could", "also", "advance", "development", "new", "checkpoint", "inhibitors", "less", "likely", "trigger", "resistance", "personalized", "immunotherapy", "checkpoint", "inhibitors", "currently", "approved", "fda", "nivolumab", "pembrolizumab", "atezolizumab", "ipilimumab", "treat", "melanoma", "lymphoma", "bladder", "lung", "head", "neck", "cancers", "drugs", "cost", "per", "month", "expense", "fueled", "efforts", "improve", "value", "patient", "selection"], "title": "Cancers evade immunotherapy by 'discarding the evidence' of tumor-specific mutations | EurekAlert! Science News", "source": "Johns Hopkins Medicine"}